The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

The global Microcarriers market, valued at US$2.03 billion in 2023, is forecasted to grow at a robust CAGR of 8.0%, reaching US$2.08 billion ...

In the vaccines segment, GSK maintained its leadership in the self-pay private market for Paediatric vaccines, the company ...

Wellness technology company OSIM has committed to improve transparency in its product information following concerns raised ...

SmartTRAK, the leading MedTech market intelligence platform in Orthopedics, Wound Care, Regenerative Medicine, and Neuro Therapies, is revolutionizing strategic decision-making with the launch of new ...

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch1 of Clindamycin Phosphate Foam, 1%. Glenmark's Clindamycin Phosphate Foam, 1% is bioequivalent and therapeutically equivalent to the ...

Being mid-period on Valentine’s Day is far from ideal, especially as many women say they neither feel sexy nor enjoy period ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

OLIPOP, Oakland, Calif., announced the successful closing of its Series C funding round, anchored by a $50 million investment ...

DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the ...

Prestige Consumer Healthcare (PBH), a leading provider of over-the-counter health products, is making strides due to persistent consumer ...